Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Melanoma and microbiota: Current understanding and future directions

28 Dec 2023

Abstract excerpt

Over the last decade, the composition of the gut microbiota has been found to correlate with the outcomes of cancer patients treated with immunotherapy. Accumulating evidence points to the various mechanisms by which intestinal bacteria act on distal tumors and how to harness this complex ecosystem to circumvent primary resistance to immune checkpoint inhibitors. Here, we review the state of the microbiota field...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Gut microbiota and health
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38157864
DOI: 10.1016/j.ccell.2023.12.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Melanoma and microbiota: Current understanding and future directionsPMID 38157864Read ↗

The gut microbiome and melanoma: A reviewSemantic proximity Read ↗

Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway InhibitionSemantic proximity Read ↗

Gut microbiota in melanoma: Effects and pathogenesesSemantic proximity Read ↗

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomesSemantic proximity Read ↗

Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in CancerSemantic proximity Read ↗

Gut microbiome in modulating immune checkpoint inhibitorsSemantic proximity Read ↗

Roles of microbiota in response to cancer immunotherapySemantic proximity Read ↗

Interaction of microbiota, mucosal malignancies, and immunotherapy—Mechanistic insightsSemantic proximity Read ↗

Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma ImmunotherapySemantic proximity Read ↗

Gut microbiota-mediated immunomodulation in tumorSemantic proximity Read ↗

Microbial mechanisms to improve immune checkpoint blockade responsivenessSemantic proximity Read ↗

Tumor-Associated Microbiome: Where Do We Stand?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.